store at low temperature
store at -80°C
Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a monoclonal antibody against phosphatidylserine (PS) with vascular targeting and immunomodulatory properties. It can reactivate anti-tumor immunity to inhibit tumor growth. Bavituximab has anti-cancer activity and is often used in combination with Paclitaxel and Carboplatin to study non-small cell lung cancer.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 114,000 |
5 mg | 在庫あり | ¥ 282,500 |
10 mg | 在庫あり | ¥ 457,000 |
25 mg | 在庫あり | ¥ 679,500 |
50 mg | 在庫あり | ¥ 900,000 |
100 mg | 在庫あり | ¥ 1,235,000 |
説明 | Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a monoclonal antibody against phosphatidylserine (PS) with vascular targeting and immunomodulatory properties. It can reactivate anti-tumor immunity to inhibit tumor growth. Bavituximab has anti-cancer activity and is often used in combination with Paclitaxel and Carboplatin to study non-small cell lung cancer. |
In vitro |
Bavituximab binds to exposed phosphatidylserine (PS) molecules through the serum protein β2-glycoprotein 1 (β2GP1)[1]. Bavituximab induces antibody-dependent cellular cytotoxicity by binding to PS, leading to the destruction of tumor vessels[1]. Bavituximab (10 μg/mL; 48 h) binds to exposed phosphatidylserine (PS) induced by 10 μM Sorafenib in HUVEC and bEnd.3 cells[2]. |
In vivo | Sorafenib induces exposure of anionic phospholipids in a mouse tumor model. Bavituximab (100 μg/mouse; i.v.; single dose; administered 48 h after Sorafenib treatment) detects phosphatidylserine exposure in vivo[2]. |
別名 | Anti-PS MAb 3G4 |
分子量 | N/A |
CAS No. | 648904-28-3 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bavituximab 648904-28-3 Others Anti-PS MAb 3G4 Inhibitor inhibitor inhibit